Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-25 @ 1:05 AM
Ignite Modification Date:
2025-12-25 @ 11:17 PM
NCT ID:
NCT05290493
Population Description:
Safety Analysis Set (SAS) includes all subjects who received at least one capsule of investigational product (IP). The numbers are different than the numbers of participants in the Participant Flow as the SAS excludes subjects who withdrew their participation prior to taking their first dose of IP. Thus, 1 subject in the Placebo/NB-001 group, and 2 subjects in the NB-001/Placebo group, were excluded from the SAS since they discontinued trial participation prior to taking any dose of IP.
Study:
NCT05290493
Study Brief:
Results Section:
NCT05290493